| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $576.3M | +34.5% |
| Cost of Revenue | $211.9M | +24.2% |
| Gross Profit | $364.4M | +41.3% |
| R&D Expense | $143.9M | +24.4% |
| SG&A Expense | $165.2M | +61.0% |
| Operating Income | -$25.7M | -129.7% |
| Interest Expense | $8.4M | +124.3% |
| Pre-tax Income | -$23.9M | -31.2% |
| Income Tax | $3.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $140.8M | -91.8% |
| Short-term Investments | $723.5M | — |
| Accounts Receivable | $53.8M | +35.9% |
| Current Assets | $946.0M | -46.6% |
| Total Assets | $1.82B | -13.6% |
| Current Liabilities | $165.5M | +184.2% |
| Long-term Debt | $1.47B | +0.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $195.2M | +46.6% |
| Capital Expenditures | $106.4M | +9.6% |
| Investing Cash Flow | -$1.15B | -910.7% |
| Financing Cash Flow | -$610.4M | -138.3% |
| Free Cash Flow | $88.8M | +146.3% |
| +201.0% |
| Net Income | -$27.8M | -42.6% |
| EPS (Basic) | -$0.28 | -33.3% |
| EPS (Diluted) | -$0.28 | -33.3% |
| Total Liabilities |
| $1.77B |
| +16.1% |
| Stockholders' Equity | $47.6M | -91.8% |